日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism

对M₁变构激动剂的进一步研究:细微的结构变化可消除M₁变构激动作用,并导致泛mAChR正构拮抗作用

Sheffler, Douglas J; Sevel, Christian; Le, Uyen; Lovell, Kimberly M; Tarr, James C; Carrington, Sheridan J S; Cho, Hyekyung P; Digby, Gregory J; Niswender, Colleen M; Conn, P Jeffrey; Hopkins, Corey R; Wood, Michael R; Lindsley, Craig W

Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode

M(1)激动剂VU0364572的化学修饰揭示了药理学中的分子开关和双位点结合模式

Digby, Gregory J; Utley, Thomas J; Lamsal, Atin; Sevel, Christian; Sheffler, Douglas J; Lebois, Evan P; Bridges, Thomas M; Wood, Michael R; Niswender, Colleen M; Lindsley, Craig W; Conn, P Jeffrey

Development of a highly selective, orally bioavailable and CNS penetrant M1 agonist derived from the MLPCN probe ML071

开发一种源自 MLPCN 探针 ML071 的高选择性、口服生物利用度高且能穿透中枢神经系统的 M1 激动剂

Lebois, Evan P; Digby, Gregory J; Sheffler, Douglas J; Melancon, Bruce J; Tarr, James C; Cho, Hyekyung P; Miller, Nicole R; Morrison, Ryan; Bridges, Thomas M; Xiang, Zixiu; Daniels, J Scott; Wood, Michael R; Conn, P Jeffrey; Lindsley, Craig W

Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders

毒蕈碱受体变构激活剂作为治疗中枢神经系统疾病的新方法

Digby, Gregory J; Shirey, Jana K; Conn, P Jeffrey

Differential dissociation of G protein heterotrimers.

G蛋白异源三聚体的差异性解离

Digby Gregory J, Sethi Pooja R, Lambert Nevin A